Esmatjes Enric, Castell Conxa, Franch Josep, Puigoriol Emma, Hernáez Rubén
Societat Catalana de Diabetis. Barcelona. Spain.
Med Clin (Barc). 2004 Jan 31;122(3):96-8. doi: 10.1016/s0025-7753(04)74155-x.
Acetylsalicylic acid (ASA) has been recommended for primary (PP) and secondary prevention (SP) of cardiovascular disease (CVD) in diabetic patients. The consumption of ASA among Catalan diabetic people is described here.
We analyzed 1,718 questionnaires administered to members of the Catalonia's Diabetic Association. ASA intake, history of CVD and medical advice about the use of ASA were evaluated.
ASA was taken by 21% subjects (as PP in 14% and as SP in 53%). Medical advice had been received in 23% (15% as PP and 56% as SP).
ASA intake among diabetic patients is low in both PP and SP. Physicians should recommend its use to improve this situation.
乙酰水杨酸(ASA)已被推荐用于糖尿病患者心血管疾病(CVD)的一级预防(PP)和二级预防(SP)。本文描述了加泰罗尼亚糖尿病患者中ASA的使用情况。
我们分析了向加泰罗尼亚糖尿病协会成员发放的1718份问卷。评估了ASA的摄入量、CVD病史以及关于使用ASA的医学建议。
21%的受试者服用了ASA(14%用于一级预防,53%用于二级预防)。23%的受试者接受了医学建议(15%用于一级预防,56%用于二级预防)。
糖尿病患者在一级预防和二级预防中ASA的摄入量均较低。医生应建议使用ASA以改善这种情况。